Silvano Cominelli

Vorstandsvorsitzender bei

GianCom AG

59 Jahre

19 Beziehungen

Health Technology

Finance

Consumer Services

Profil

Silvano Cominelli is currently Chief Executive Officer & Chief Investment Officer at GianCom AG since 2017.
Formerly, Dr. Cominelli was Director at Broncus Technologies, Inc. from 2007 to 2013, Director at Pelikan Technologies, Inc., Director-Neurology Business Unit at Serono SA from 1998 to 2000, and Investment Advisor at HBM Partners AG (Investment Management).
Dr. Cominelli earned a doctorate from the University of Zurich in 1999.

Aktive Positionen von Silvano Cominelli

Unternehmen	Position	Beginn
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Vorstandsvorsitzender	20.09.2017

Alle aktiven Positionen von Silvano Cominelli

Ehemalige bekannte Positionen von Silvano Cominelli

Unternehmen	Position	Ende
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Direktor/Vorstandsmitglied	01.02.2013
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Corporate Officer/Principal	01.12.2000
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Analyst-Equity	-
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Silvano Cominelli im Detail an

Ausbildung von Silvano Cominelli

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Silvano Cominelli im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	6
Broncus Technologies, Inc. Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Develops solutions for diagnosing and treating lung diseases	Health Technology
Pelikan Technologies, Inc. Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Develops hand held diagnostic and monitoring devices	Health Technology
Serono SA Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs	Health Technology
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HBM Partners AG (Investment Management) HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs.	Finance
GianCom AG GianCom AG Investment ManagersFinance GianCom specializes in global equity investments, predominantly in growth sectors and compounders in the industries health care, technology, consumer and industrials with a focus on developed countries. The firm incorporates a fundamental, bottom-up stock picking process. Investment decisions are based on in-depth fundamental research into a company’s financial and business strengths/weaknesses, its growth prospect and unique industry positioning as well as the quality of management and capital returns.	Finance